BridgePort Financial Solutions’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$424K Sell
8,090
-565
-7% -$29.9K 0.11% 149
2026
Q1
$478K Sell
8,655
-5
-0.1% -$271 0.14% 130
2025
Q4
$425K Buy
8,660
+107
+1% +$4.99K 0.11% 144
2025
Q3
$369K Buy
8,553
+138
+2% +$5.39K 0.1% 157
2025
Q2
$323K Buy
8,415
+87
+1% +$3.32K 0.11% 147
2025
Q1
$323K Buy
8,328
+10
+0.1% +$366 0.15% 120
2024
Q4
$310K Buy
+8,318
New +$299K 0.14% 129

Other funds holding GSK

BridgePort Financial Solutions's GSK Position: Q2 2026 in Review

BridgePort Financial Solutions reduced its GSK (GSK) stake by 6.5% in Q2 2026, selling an estimated $29.9K and leaving 8,090 shares worth $424K. The position accounts for 0.11% of the portfolio, ranked #149.

BridgePort Financial Solutions first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $478K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • BridgePort Financial Solutions held 8,090 shares of GSK worth $424K as of Q2 2026.
  • BridgePort Financial Solutions sold 565 GSK shares in Q2 2026, an estimated $29.9K.
  • GSK made up 0.11% of BridgePort Financial Solutions's portfolio in Q2 2026, its #149 holding.
  • BridgePort Financial Solutions first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • BridgePort Financial Solutions's GSK position peaked at $478K in Q1 2026.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on BridgePort Financial Solutions's 13F filing for Q2 2026, filed 24 Jul 2026.